Cargando…

Trajectory and Demographic Correlates of Antibodies to SARS-CoV-2 Nucleocapsid in Recently Infected Blood Donors, United States

We evaluated antibodies to the nucleocapsid protein of SARS-CoV-2 in a large cohort of blood donors in the United States who were recently infected with the virus. Antibodies to the nucleocapsid protein of SARS-CoV-2 indicate previous infection but are subject to waning, potentially affecting epidem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haynes, James M., Dodd, Roger Y., Crowder, Lauren A., Notari, Edward P., Stramer, Susan L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310359/ https://www.ncbi.nlm.nih.gov/pubmed/37163762 http://dx.doi.org/10.3201/eid2907.230173

Ejemplares similares

A Longitudinal Study of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response in a Subset of United States Blood Donors
por: Tonnetti, Laura, et al.
Publicado: (2022)

Risk factors and epidemiology of human T-lymphotropic virus types 1 and 2 in US blood donors
por: Vahidnia, Farnaz, et al.
Publicado: (2015)

Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines
por: Dodd, Roger Y, et al.
Publicado: (2021)

Comment on: "Temporal distribution of blood donations in three Brazilian blood centers and its repercussion on the blood supply"
por: Dodd, Roger, et al.
Publicado: (2013)

Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program
por: Stone, Mars, et al.
Publicado: (2021)

COVID-19 and Blood Safety: Help with a Dilemma
por: Dodd, Roger Y., et al.
Publicado: (2020)

Monkeypox and Transfusion Safety
por: Dodd, Roger Y., et al.
Publicado: (2023)

Production and Characterization of Monoclonal Antibodies Against the Nucleocapsid Protein of SARS-COV
por: Fang, Ying, et al.
Publicado: (2006)

Seroconverting Blood Donors as a Resource for Characterising and Optimising Recent Infection Testing Algorithms for Incidence Estimation
por: Kassanjee, Reshma, et al.
Publicado: (2011)

Antibodies to Nucleocapsid Are Not Diagnostic for Long COVID
por: Brandt, C. T., et al.
Publicado: (2023)

Emerging Infectious Diseases That Threaten the Blood Supply
por: Alter, Harvey J., et al.
Publicado: (2007)

Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status — United States, April 2021–September 2022
por: Jones, Jefferson M., et al.
Publicado: (2023)

Childhood body mass index trajectories: modeling, characterizing, pairwise correlations and socio-demographic predictors of trajectory characteristics
por: Wen, Xiaozhong, et al.
Publicado: (2012)

Detection of Anti-Nucleocapsid Antibody in COVID-19 Patients in Bangladesh Is not Correlated with Previous Dengue Infection
por: Lytton, Simon D., et al.
Publicado: (2021)

Genetic Variability of West Nile Virus in US Blood Donors, 2002–2005
por: Grinev, Andriyan, et al.
Publicado: (2008)

Tracking hantavirus nucleocapsid protein using intracellular antibodies
por: Li, Jiandong, et al.
Publicado: (2010)

Nucleocapsid-Specific Antibodies as a Correlate of Protection against SARS-CoV-2 Reinfection in Children
por: Dowell, Alexander C., et al.
Publicado: (2023)

Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43()
por: Blanchard, Elisabeth G., et al.
Publicado: (2011)

(Non‐)donor demographics, donation willingness, and the donor career
por: Piersma, Tjeerd W., et al.
Publicado: (2019)

Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results
por: Perkmann, Thomas, et al.
Publicado: (2021)

Antibody Screening Results for Anti-Nucleocapsid Antibodies Toward the Development of a Lateral Flow Assay to Detect SARS-CoV-2 Nucleocapsid Protein
por: Cate, David M., et al.
Publicado: (2021)

County-level demographic, social, economic, and lifestyle correlates of COVID-19 infection and death trajectories during the first wave of the pandemic in the United States
por: DuPre, Natalie C., et al.
Publicado: (2021)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

Correlation of West Nile Virus Incidence in Donated Blood with West Nile Neuroinvasive Disease Rates, United States, 2010–2012
por: Betsem, Edouard, et al.
Publicado: (2017)

West Nile Virus Infections Projected from Blood Donor Screening Data, United States, 2003
por: Busch, Michael P., et al.
Publicado: (2006)

Household Socioeconomic and Demographic Correlates of Cryptosporidium Seropositivity in the United States
por: Becker, Daniel J., et al.
Publicado: (2015)

Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
por: Terry, James S., et al.
Publicado: (2020)

Antibody against nucleocapsid protein predicts susceptibility to human coronavirus infection
por: Gao, Xin, et al.
Publicado: (2015)

Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen
por: Dobaño, Carlota, et al.
Publicado: (2022)

451. Is Antibody to Nucleocapsid More Prevalent in Individuals with Severe COVID-19?
por: Patel, Hemang, et al.
Publicado: (2021)

Reply to Brandt et al., “Antibodies to Nucleocapsid Are Not Diagnostic for Long COVID”
por: Fogh, Kamille, et al.
Publicado: (2023)

Socio-demographic characteristics of Danish blood donors
por: Burgdorf, Kristoffer Sølvsten, et al.
Publicado: (2017)

IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients
por: Yang, Li, et al.
Publicado: (2021)

Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies
por: Loesche, Michael, et al.
Publicado: (2022)

Evidence of likely autochthonous Chagas disease in the southwestern United States: A case series of Trypanosoma cruzi seropositive blood donors
por: Lynn, Mary K., et al.
Publicado: (2022)

Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11
por: Cheng, Man, et al.
Publicado: (2005)

Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody
por: Terry, James S., et al.
Publicado: (2021)

Antibodies Produced Toward Recombinant RBD and Nucleocapsid Neutralize SARS-COV-2
por: Rezaei, Amir, et al.
Publicado: (2022)

Nucleocapsid Assembly of Baculoviruses
por: Zhao, Shuling, et al.
Publicado: (2019)

Demographic determinants of syphilis seroprevalence among U.S. blood donors, 2011–2012
por: Kane, Mark Andrew, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k3is4tv9no8v7cjt6amnmfsnqj